Levodopa and survival
Garcia de Yebenes, J.; Giminez Roldán, S.; Chacón, J.; Pastor, M.
Neurology 44(9): 1771-1772
1994
ISSN/ISBN: 0028-3878 PMID: 7936326 Document Number: 424301
Document emailed within 1 workday
Related Documents
Timberlake, W.H. 1970: Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders Neurology 20(12): 31-35Barbeau, A. 1972: The use of levodopa in diseases other than Parkinsonism L'Union Medicale du Canada 101(5): 849-852
Slama, R.; Coumel, P.; Waynberger, M.; Motte, G. 1972: Levodopa and ECG wave bursts La Nouvelle Presse Medicale 1(43): 2904
Burguera, J.A.; Grandas, F.; Horga de la Parte, J.F.; Luquin, R.; Martí, F.; Matías-Guiu, J.; Obeso, J.A.; Kulisevsky, J. 1999: Entacapone: is it useful as complimentary treatment with levodopa? Revista de Neurologia 28(8): 817-834
Khosla, S.N.; Khosla, P. 1983: Treatment of hepatic coma with levodopa Journal of the Association of Physicians of India 31(7): 441-442
Agid, Y.; Agid, Y. 2001: Levodopa. Is toxicity a myth? 1998 Neurology 57(10 Suppl 3: S46-S51
Stennett, D.J.; Christensen, J.M.; Anderson, J.L.; Parrott, K.A. 1986: Stability of levodopa in 5% dextrose injection at pH 5 or 6 American Journal of Hospital Pharmacy 43(7): 1726-1728
Hauser, R.A. 2004: Levodopa/carbidopa/entacapone (Stalevo) Neurology 62(1 Suppl 1): S64-S71
Ozsoylu, S.; Koçak, N.; Gürgey, A. 1975: Levodopa in hepatic coma in children Turkish Journal of Pediatrics 17(1-2): 5-14
Faglioni, P.; Gasparini, M.; Spinnler, H. 1975: Outcome of Parkinsonism after two years of levodopa plus R04-4602 Rivista di Patologia Nervosa E Mentale 96(4): 270-286
Jankovic, J.; Lai, E.C.; Krauss, J.; Grossman, R. 1999: Surgical treatment of levodopa-induced dyskinesias Advances in Neurology 80: 603-609
Itoh, H.; Nakamura, S.; Akiguchi, I.; Yamao, S.; Kameyama, M. 1987: Levodopa therapy in a patient with ALS-dementia complex Rinsho Shinkeigaku 27(9): 1145-1149
Cabo-López, I.; García-Bermejo, P.; García-Ruiz, P.J. 2007: Levodopa withdrawal symptoms in a non-Parkinsonian patient Revista de Neurologia 45(3): 190
Herbison, G.J. 1973: H-reflex in patients with parkinsonism: effect of levodopa Archives of Physical Medicine and Rehabilitation 54(7): 291-295 Passim
Botteri, A.; Nordström, P.O. 1979: Connection between levodopa therapy and malignant tumors Lakartidningen 76(5): 316-317
Przybilla, B.; Schwab, U.; Landthaler, M.; Braun-Falco, O. 1985: Development of two malignant melanomas during administration of levodopa Acta Dermato-Venereologica 65(6): 556-557
Rascol, O. 2000: Medical treatment of levodopa-induced dyskinesias Annals of Neurology 47(4 Suppl 1): S179-S188
Białecka, M.; Adamiak, U.; Gawrońska-Szklarz, B. 2009: Optimisation of treatment of Parkinson's disease with levodopa Neurologia i Neurochirurgia Polska 43(5): 446-459
Rascol, O.; Salachas, F.; Montastruc, J.L. 1990: Neuroleptic malignant-like syndrome following levodopa withdrawal Revue Neurologique (Paris) 146(3): 215-218
Klivényi, P.ét.; Vécsei, L.ás.ó 2014: Clinical studies with levodopa/carbidopa intestinal gel Ideggyogyaszati Szemle 67(1-2): 5-8